Literature DB >> 33268499

Prdm16 is a critical regulator of adult long-term hematopoietic stem cell quiescence.

Kristbjorn O Gudmundsson1, Nhu Nguyen1, Kevin Oakley1, Yufen Han1, Bjorg Gudmundsdottir2, Pentao Liu3, Lino Tessarollo4, Nancy A Jenkins5, Neal G Copeland6, Yang Du7.   

Abstract

Regulation of quiescence is critical for the maintenance of adult hematopoietic stem cells (HSCs). Disruption of transcription factor gene Prdm16 during mouse embryonic development has been shown to cause a severe loss of fetal liver HSCs; however, the underlying mechanisms and the function of Prdm16 in adult HSCs remain unclear. To investigate the role of Prdm16 in adult HSCs, we generated a novel conditional knockout mouse model and deleted Prdm16 in adult mouse hematopoietic system using the IFN-inducible Mx1-Cre Our results show that Prdm16 deletion in the adult mouse hematopoietic system has a less severe effect on HSCs, causing a gradual decline of adult HSC numbers and a concomitant increase in the multipotent progenitor (MPP) compartment. Prdm16 deletion in the hematopoietic system following transplantation produced the same phenotype, indicating that the defect is intrinsic to adult HSCs. This HSC loss was also exacerbated by stress induced by 5-fluorouracil injections. Annexin V staining showed no difference in apoptosis between wild-type and knockout adult HSCs. In contrast, Bromodeoxyuridine analysis revealed that loss of Prdm16 significantly increased cycling of long-term HSCs (LT-HSCs) with the majority of the cells found in the S to G2/M phase. Consistently, RNA sequencing analysis of mouse LT-HSCs with and without Prdm16 deletion showed that Prdm16 loss induced a significant decrease in the expression of several known cell cycle regulators of HSCs, among which Cdkn1a and Egr1 were identified as direct targets of Prdm16 Our results suggest that Prdm16 preserves the function of adult LT-HSCs by promoting their quiescence.

Entities:  

Keywords:  Prdm16; hematopoietic stem cells; quiescence

Mesh:

Substances:

Year:  2020        PMID: 33268499      PMCID: PMC7749346          DOI: 10.1073/pnas.2017626117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  The journey of developing hematopoietic stem cells.

Authors:  Hanna K A Mikkola; Stuart H Orkin
Journal:  Development       Date:  2006-10       Impact factor: 6.868

2.  p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70.

Authors:  Peng Zou; Hiroki Yoshihara; Kentaro Hosokawa; Ikue Tai; Kaori Shinmyozu; Fujiko Tsukahara; Yoshiro Maru; Keiko Nakayama; Keiichi I Nakayama; Toshio Suda
Journal:  Cell Stem Cell       Date:  2011-09-02       Impact factor: 24.633

3.  Prdm16 is a physiologic regulator of hematopoietic stem cells.

Authors:  Francesca Aguilo; Serine Avagyan; Amy Labar; Ana Sevilla; Dung-Fang Lee; Parameet Kumar; Ihor R Lemischka; Betty Y Zhou; Hans-Willem Snoeck
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

4.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

5.  PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Authors:  Bo Zhou; Jingya Wang; Shirley Y Lee; Jie Xiong; Natarajan Bhanu; Qi Guo; Peilin Ma; Yuqing Sun; Rajesh C Rao; Benjamin A Garcia; Jay L Hess; Yali Dou
Journal:  Mol Cell       Date:  2016-04-14       Impact factor: 17.970

6.  A highly efficient recombineering-based method for generating conditional knockout mutations.

Authors:  Pentao Liu; Nancy A Jenkins; Neal G Copeland
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

7.  E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors.

Authors:  Craig L Semerad; Elinore M Mercer; Matthew A Inlay; Irving L Weissman; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

8.  Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.

Authors:  Hanno Hock; Melanie J Hamblen; Heather M Rooke; Jeffrey W Schindler; Shireen Saleque; Yuko Fujiwara; Stuart H Orkin
Journal:  Nature       Date:  2004-09-29       Impact factor: 49.962

9.  Prolonged expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells.

Authors:  S Okada; T Fukuda; K Inada; T Tokuhisa
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

10.  The transcriptional landscape of hematopoietic stem cell ontogeny.

Authors:  Shannon McKinney-Freeman; Patrick Cahan; Hu Li; Scott A Lacadie; Hsuan-Ting Huang; Matthew Curran; Sabine Loewer; Olaia Naveiras; Katie L Kathrein; Martina Konantz; Erin M Langdon; Claudia Lengerke; Leonard I Zon; James J Collins; George Q Daley
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

View more
  9 in total

1.  Identification and characterization of in vitro expanded hematopoietic stem cells.

Authors:  James L C Che; Daniel Bode; Iwo Kucinski; Alyssa H Cull; Fiona Bain; Hans J Becker; Maria Jassinskaja; Melania Barile; Grace Boyd; Miriam Belmonte; Andy G X Zeng; Kyomi J Igarashi; Juan Rubio-Lara; Mairi S Shepherd; Anna Clay; John E Dick; Adam C Wilkinson; Hiromitsu Nakauchi; Satoshi Yamazaki; Berthold Göttgens; David G Kent
Journal:  EMBO Rep       Date:  2022-08-16       Impact factor: 9.071

2.  Epigenetic modifier SMCHD1 maintains a normal pool of long-term hematopoietic stem cells.

Authors:  Sarah A Kinkel; Joy Liu; Tamara Beck; Kelsey A Breslin; Megan Iminitoff; Peter Hickey; Marnie E Blewitt
Journal:  iScience       Date:  2022-06-30

3.  Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

Authors:  Yomna M El-Meligui; Naglaa M Hassan; Amira B Kassem; Nora A Gouda; Marwa Mohanad; Manal A Hamouda; Ahmad Salahuddin
Journal:  Pharmgenomics Pers Med       Date:  2022-06-25

4.  HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.

Authors:  Liping Li; Jung-Hyun Kim; Wenyan Lu; Donna M Williams; Joseph Kim; Leslie Cope; Raajit K Rampal; Richard P Koche; Lingling Xian; Li Z Luo; Marija Vasiljevic; Daniel R Matson; Zhizhuang Joe Zhao; Ophelia Rogers; Matthew C Stubbs; Karen Reddy; Antonio-Rodriguez Romero; Bethan Psaila; Jerry L Spivak; Alison R Moliterno; Linda M S Resar
Journal:  Blood       Date:  2022-05-05       Impact factor: 25.476

5.  Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors.

Authors:  Natassia Robinson; John Casement; Marc J Gunter; Inge Huybrechts; Antonio Agudo; Miguel Rodríguez Barranco; Fabian Eichelmann; Theron Johnson; Rudolf Kaaks; Valeria Pala; Salvatore Panico; Torkjel M Sandanger; Matthias B Schultze; Ruth C Travis; Rosario Tumino; Paolo Vineis; Elisabete Weiderpass; Roderick Skinner; Linda Sharp; Jill A McKay; Gordon Strathdee
Journal:  Br J Cancer       Date:  2022-03-30       Impact factor: 9.075

Review 6.  PRDM16 Regulating Adipocyte Transformation and Thermogenesis: A Promising Therapeutic Target for Obesity and Diabetes.

Authors:  Na Jiang; Ming Yang; Yachun Han; Hao Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

7.  CDK19 regulates the proliferation of hematopoietic stem cells and acute myeloid leukemia cells by suppressing p53-mediated transcription of p21.

Authors:  Zihao Zhang; Yukai Lu; Yan Qi; Yang Xu; Song Wang; Fang Chen; Mingqiang Shen; Mo Chen; Naicheng Chen; Lijing Yang; Shilei Chen; Fengchao Wang; Yongping Su; Mengjia Hu; Junping Wang
Journal:  Leukemia       Date:  2022-02-02       Impact factor: 12.883

8.  CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.

Authors:  Hannah Lawson; Louie N van de Lagemaat; Melania Barile; Andrea Tavosanis; Jozef Durko; Arnaud Villacreces; Aarushi Bellani; Christopher Mapperley; Elise Georges; Catarina Martins-Costa; Catarina Sepulveda; Lewis Allen; Joana Campos; Kirsteen J Campbell; Dónal O'Carroll; Berthold Göttgens; Suzanne Cory; Neil P Rodrigues; Amelie V Guitart; Kamil R Kranc
Journal:  Stem Cell Reports       Date:  2021-10-28       Impact factor: 7.765

9.  Defining the Hoxb8 cell lineage during murine definitive hematopoiesis.

Authors:  Donn A Van Deren; Shrutokirti De; Ben Xu; Kayla M Eschenbacher; Shuhua Zhang; Mario R Capecchi
Journal:  Development       Date:  2022-04-22       Impact factor: 6.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.